Type 1 diabetes

Effect of 48 Months of Closed-Loop Insulin Delivery on Residual C-Peptide Secretion and Glycemic Control in Newly Diagnosed Youth With Type 1 Diabetes: A Randomized Trial

Diabetes CarePublished Extension phase of a randomised controlled trial

Primary result · Fasting C-peptide corrected for fasting glucoseResult — go to the resultMean adjusted difference −2 pmol/L per mmol/L 95% CI −7 to 4

Authors' conclusion

Improved glycemic control was sustained over 48 months after diagnosis with CL insulin delivery compared with standard therapy in youth with type 1 diabetes. This did not appear to confer a protective effect on residual C-peptide secretion.

Study context

Population
Newly diagnosed youth with T1D aged 10 to 16.9 years, continuing after the 24-month primary phase until 48 months after diagnosisextension phase
Participants
81 participants
Comparison
Hybrid closed-loop vs standard insulin therapy
  • Closed-loop (CL)n = 47
  • Controln = 34reference
Primary endpoint
Fasting C-peptide corrected for fasting glucose
Follow-up
48 months
Methodological detailsmulticenter, parallel, intention-to-treat
  • Multicenter
  • Parallel
  • Intention-to-treat

Primary result

As reported in the abstract

Mean adjusted difference

−2 pmol/L per mmol/L

95% CI −7 to 4

P = 0.54

By group

CLvs Control
mean adjusted difference −2 pmol/L per mmol/L (95% CI −7 to 4); P = 0.54

Further findings

OutcomeDifference (%) (95% CI)P value
Central laboratory HbA1c · 48 monthsCLvs ControlLower with CL0.9 (0.2–1.5)P = 0.009
OutcomeDifference (mmol/mol) (95% CI)P value
Central laboratory HbA1c · 48 monthsCLvs ControlLower with CL10 (3–17)P = 0.009
OutcomeDifference (percentage points) (95% CI)P value
TIR 3.9 to 10.0 mmol/L12 (3–20)P = 0.008

Safety

Events

OutcomeCLControl
Severe hypoglycemic events · extension phase65
DKA events · extension phase34
Severe hypoglycemic events — Total severe hypoglycemic events
11
DKA events — Total DKA events
7

Original publication

Effect of 48 Months of Closed-Loop Insulin Delivery on Residual C-Peptide Secretion and Glycemic Control in Newly Diagnosed Youth With Type 1 Diabetes: A Randomized Trial. Diabetes Care. Published 26 June 2024. doi:10.2337/dc24-0360

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.